Renaissance Technologies
OTLK icon

Renaissance Technologies’s Outlook Therapeutics OTLK Stock Holding History

Renaissance Technologies’s Portfolio OTLK Stock Details OTLK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-255,157
Closed -$52.5K – 3527
2026
Q1 		$52.5K Buy
+255,157
New +$110K ﹤0.01% 3107
2025
Q3 		– Sell
-106,068
Closed -$170K – 3793
2025
Q2 		$170K Buy
+106,068
New +$169K ﹤0.01% 3200
2025
Q1 		– Sell
-130,374
Closed -$246K – 3738
2024
Q4 		$246K Buy
+130,374
New +$536K ﹤0.01% 3103
2024
Q2 		– Sell
-17,600
Closed -$210K – 3840
2024
Q1 		$210K Buy
17,600
+12,329
+234% +$99.7K ﹤0.01% 3213
2023
Q4 		$42K Buy
+5,271
New +$44.6K ﹤0.01% 3482
2022
Q4 		– Sell
-2,515
Closed -$61K – 4316
2022
Q3 		$61K Sell
2,515
-8,055
-76% -$187K ﹤0.01% 3707
2022
Q2 		$216K Sell
10,570
-25,890
-71% -$744K ﹤0.01% 3617
2022
Q1 		$1.3M Sell
36,460
-21,755
-37% -$679K ﹤0.01% 2546
2021
Q4 		$1.58M Buy
58,215
+45,476
+357% +$1.62M ﹤0.01% 2337
2021
Q3 		$553K Buy
+12,739
New +$615K ﹤0.01% 2852
2021
Q2 		– Sell
-41,628
Closed -$1.87M – 3691
2021
Q1 		$1.87M Buy
41,628
+38,893
+1,422% +$1.49M ﹤0.01% 2275
2020
Q4 		$71K Sell
2,735
-2,605
-49% -$54.4K ﹤0.01% 3297
2020
Q3 		$77K Buy
+5,340
New +$119K ﹤0.01% 3246
2020
Q1 		– Sell
-1,970
Closed -$23K – 3690
2019
Q4 		$23K Buy
+1,970
New +$45.9K ﹤0.01% 3443
2019
Q2 		– Sell
-558
Closed -$83K – 3709
2019
Q1 		$83K Buy
+558
New +$78.8K ﹤0.01% 3319

Other funds holding OTLK

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
GWM
Gilpin Wealth Management Denver, Colorado $145M AUM

Renaissance Technologies's OTLK Position: Q2 2026 in Review

Renaissance Technologies sold out of Outlook Therapeutics (OTLK) in Q2 2026, closing a stake of 255,157 shares — an estimated $52.5K sold.

Renaissance Technologies first reported a position in OTLK in Q1 2019 and held it in 15 quarters. The position peaked at $1.87M in Q1 2021. 69 funds tracked by Wall St. Rank hold OTLK as of Q2 2026.

  • Renaissance Technologies reported no remaining Outlook Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Renaissance Technologies sold 255,157 Outlook Therapeutics shares in Q2 2026, an estimated $52.5K.
  • Renaissance Technologies first reported a position in Outlook Therapeutics in Q1 2019 and held it in 15 quarters.
  • Renaissance Technologies's Outlook Therapeutics position peaked at $1.87M in Q1 2021.
  • 69 funds tracked by Wall St. Rank held Outlook Therapeutics as of Q2 2026.

Based on Renaissance Technologies's 13F filing for Q2 2026, filed 13 Aug 2026.